PPGN — PolyPeptide AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for PolyPeptide AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	136	37.5	95.7	68.3	74.6
Net Total Accounts Receivable
Net Total Receivables	75.9	62.4	96	107	88
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	332	252	327	328	325
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	235	297	324	389	459
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	595	576	689	757	826
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	104	96.1	176	195	187
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	174	154	308	399	485
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	421	422	381	357	341
Total Liabilities & Shareholders' Equity	595	576	689	757	826
Total Common Shares Outstanding